Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs.
Roys H, Arykbayeva A, Friedman SK, Gifford G, Palmer ER, Rogers A, Tran ENH, Fry L, Weaver A, Bowlin A, Jones MD, Eledge MR, Boehme KW, Naumiec GR, Weinkopff T.
Roys H, et al. Among authors: fry l.
bioRxiv [Preprint]. 2024 Aug 24:2024.08.23.605637. doi: 10.1101/2024.08.23.605637.
bioRxiv. 2024.
PMID: 39229173
Free PMC article.
Preprint.